By Adriano Marchese
NeoGenomics appointed Abhishek Jain to the role of chief financial officer, succeeding Jeff Sherman, who is set to retire from the position in March.
Jain brings to the cancer-diagnostics company a wealth of experience in the life sciences sector, most recently as CFO of CareDx, a publicly traded precision medicine company, for the past three years.
Prior to that, Jain served for nearly 20 years in finance and accounting roles of increasing responsibility at Agilent Technologies, an analytical and clinical laboratory technologies company.
Jain's appointment to the CFO position is effective on March 2, which is when Sherman is set to officially retire.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
January 12, 2026 07:40 ET (12:40 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments